MUCE: Bayesian hierarchical modelling for the design and analysis of phase 1b multiple expansion cohort trials

RoBoT: a robust Bayesian hypothesis testing method for basket trials

(2020) Tianjian Zhou et al.   BIOSTATISTICS

The i3+3 design for phase I clinical trials

(2019) Meizi Liu et al.   Journal of Biopharmaceutical Statistics

Borrowing strength and borrowing index for Bayesian hierarchical models

(2019) Ganggang Xu et al.   COMPUTATIONAL STATISTICS & DATA ANALYSIS

A Bayesian basket trial design using a calibrated Bayesian hierarchical model

(2018) Yiyi Chu et al.   Clinical Trials

Bayesian basket trial design with exchangeability monitoring

(2018) Brian P. Hobbs et al.   STATISTICS IN MEDICINE

The Bayesian basket design for genomic variant-driven phase II trials

(2016) Richard Simon et al.   SEMINARS IN ONCOLOGY

Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations

(2015) David M. Hyman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Robust exchangeability designs for early phase clinical trials with multiple strata

(2015) Beat Neuenschwander et al.   PHARMACEUTICAL STATISTICS

Bayesian hierarchical modeling of patient subpopulations: Efficient designs of Phase II oncology clinical trials

(2013) Scott M Berry et al.   Clinical Trials

Bayes and empirical-Bayes multiplicity adjustment in the variable-selection problem

(2010) James G. Scott et al.   ANNALS OF STATISTICS

A weakly informative default prior distribution for logistic and other regression models

(2009) Andrew Gelman et al.   Annals of Applied Statistics

Phase II, Open-Label Study Evaluating the Activity of Imatinib in Treating Life-Threatening Malignancies Known to Be Associated with Imatinib-Sensitive Tyrosine Kinases

(2008) M. C. Heinrich et al.   CLINICAL CANCER RESEARCH

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER